Earnings Call · Q4 FY2025·2026-02-26

Q4 25EPS +100.00%*·Rev n/aQ3 25EPS -82.86%·Rev n/aQ2 25EPS -23.33%·Rev n/aQ1 25EPS +24.24%·Rev n/a⚠ consensus missing

Natera, Inc. NTRA

Mike Brophy — Chief Financial Officer

Steve Chapman — Chief Executive Officer

Solomon Moshkevich — President, Clinical Diagnostics

Alexey Aleshin — General Manager of Oncology and Chief Medical Officer

John Fesko — Role not explicitly stated, likely senior executive or head of a division

+0.5%1d on move date+0.3% vs SPY3d+2.1%5d−1.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NTRA calls or request research access.

More NTRA calls Browse calls Request research access